A detailed history of Midwest Professional Planners, Ltd. transactions in Amgen Inc stock. As of the latest transaction made, Midwest Professional Planners, Ltd. holds 8,397 shares of AMGN stock, worth $2.21 Million. This represents 0.83% of its overall portfolio holdings.

Number of Shares
8,397
Previous 8,067 4.09%
Holding current value
$2.21 Million
Previous $2.52 Million 7.34%
% of portfolio
0.83%
Previous 0.85%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$309.38 - $337.38 $102,095 - $111,335
330 Added 4.09%
8,397 $2.71 Million
Q2 2024

Aug 06, 2024

SELL
$262.75 - $319.31 $5,517 - $6,705
-21 Reduced 0.26%
8,067 $2.52 Million
Q1 2024

May 09, 2024

SELL
$268.87 - $324.56 $40,599 - $49,008
-151 Reduced 1.83%
8,088 $2.3 Million
Q4 2023

Feb 15, 2024

BUY
$255.7 - $288.46 $147,538 - $166,441
577 Added 7.53%
8,239 $2.37 Million
Q3 2023

Nov 13, 2023

BUY
$218.65 - $271.46 $186,289 - $231,283
852 Added 12.51%
7,662 $2.06 Million
Q2 2023

Aug 07, 2023

BUY
$214.27 - $253.37 $181,915 - $215,111
849 Added 14.24%
6,810 $1.51 Million
Q1 2023

May 15, 2023

SELL
$225.79 - $275.2 $16,031 - $19,539
-71 Reduced 1.18%
5,961 $1.44 Million
Q4 2022

Feb 10, 2023

BUY
$229.03 - $291.01 $100,544 - $127,753
439 Added 7.85%
6,032 $1.58 Million
Q3 2022

Nov 10, 2022

BUY
$224.46 - $253.15 $93,150 - $105,057
415 Added 8.01%
5,593 $1.26 Million
Q2 2022

Aug 09, 2022

BUY
$230.71 - $256.74 $72,212 - $80,359
313 Added 6.43%
5,178 $1.26 Million
Q1 2022

May 11, 2022

BUY
$219.27 - $242.57 $69,947 - $77,379
319 Added 7.02%
4,865 $1.18 Million
Q4 2021

Feb 10, 2022

BUY
$198.88 - $227.6 $26,252 - $30,043
132 Added 2.99%
4,546 $1.02 Million
Q3 2021

Nov 08, 2021

BUY
$212.27 - $248.7 $10,613 - $12,435
50 Added 1.15%
4,414 $939,000
Q2 2021

Aug 10, 2021

BUY
$233.58 - $259.14 $142,950 - $158,593
612 Added 16.31%
4,364 $1.06 Million
Q1 2021

May 17, 2021

SELL
$221.91 - $258.6 $114,061 - $132,920
-514 Reduced 12.05%
3,752 $761,000
Q4 2020

Mar 11, 2021

BUY
$216.38 - $257.67 $22,719 - $27,055
105 Added 2.52%
4,266 $981,000
Q3 2020

Nov 06, 2020

BUY
$234.65 - $260.95 $58,427 - $64,976
249 Added 6.37%
4,161 $1.06 Million
Q2 2020

Aug 14, 2020

BUY
$197.81 - $242.74 $31,649 - $38,838
160 Added 4.26%
3,912 $923,000
Q1 2020

May 05, 2020

BUY
$182.24 - $241.7 $24,602 - $32,629
135 Added 3.73%
3,752 $761,000
Q4 2019

Feb 11, 2020

BUY
$189.21 - $243.2 $20,623 - $26,508
109 Added 3.11%
3,617 $872,000
Q3 2019

Nov 14, 2019

BUY
$174.11 - $208.62 $217,985 - $261,192
1,252 Added 55.5%
3,508 $679,000
Q2 2019

Aug 12, 2019

BUY
$166.7 - $195.41 $1,833 - $2,149
11 Added 0.49%
2,256 $416,000
Q1 2019

May 08, 2019

SELL
$180.87 - $203.88 $359,750 - $405,517
-1,989 Reduced 46.98%
2,245 $427,000
Q4 2018

Feb 14, 2019

SELL
$178.4 - $208.25 $7,492 - $8,746
-42 Reduced 0.98%
4,234 $824,000
Q3 2018

Nov 13, 2018

BUY
$185.29 - $208.89 $20,381 - $22,977
110 Added 2.64%
4,276 $886,000
Q2 2018

Aug 10, 2018

BUY
$166.05 - $186.51 $16,771 - $18,837
101 Added 2.48%
4,166 $769,000
Q1 2018

May 15, 2018

BUY
$169.43 - $198.0 $22,195 - $25,938
131 Added 3.33%
4,065 $693,000
Q4 2017

Feb 13, 2018

BUY
$168.79 - $188.59 $664,019 - $741,913
3,934
3,934 $684,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $141B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Midwest Professional Planners, Ltd. Portfolio

Follow Midwest Professional Planners, Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Midwest Professional Planners, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Midwest Professional Planners, Ltd. with notifications on news.